BASF's Growth Pipeline Meets a Skeptical Spotlight Ahead of Capital Markets Day
Published on 11/18/2026 at 15:21 | Editorial boerse-global.deBASF is stacking up expansion moves across its portfolio — a methanol technology tie-up, a new soybean trait platform, a billion-dollar MDI plant in Louisiana and the divestment of its mining chemicals arm — yet the market's attention is fixed on a single question: can the chemicals giant deliver the earnings it has promised?
Jefferies doesn't think so, at least not in agriculture. Analyst Priyanka Patel reiterated an "Underperform" rating and a 44 euro price target on the stock, flagging that BASF's crop-science ambitions sit above both consensus and her own modelling. The company is targeting an operating result of 2.35–2.6 billion euros in the agricultural segment by 2028; Patel's forecast stands at 2.1 billion euros. That gap is the crux of the bear case, and it explains why the shares slipped 0.6% in today's session.
A Methanol Bet Built on Modules
On the growth side of the ledger, BASF has agreed to collaborate with DWE to accelerate the rollout of modular plants for sustainable methanol. The concept pairs BASF's SYNSPIRE methanol synthesis catalysts with DWE's power-to-liquid technology, aimed squarely at small and mid-sized projects. Pre-engineered units are designed to speed up installation and allow capacity to be added in stages — a structure that could spare developers from committing to full-scale capacity upfront.
The plants can run at 30–100% load, and additional parallel modules can be bolted on as demand grows. BASF's catalysts are intended to underpin productivity, reliability and long run times. Synthetic methanol made from renewable energy and non-fossil carbon sources would offer an alternative to its fossil-based counterpart, and the units can be integrated at both greenfield and existing sites.
Should investors sell immediately? Or is it worth buying BASF?
For investors, the appeal lies in scalability: growth would no longer hinge on a handful of mega-projects. Still, a technically elegant partnership is not the same as an earnings contribution. The test will be whether the concept translates into economically viable projects that pull through demand for BASF's catalysts.
Soybean Technology and a Louisiana Milestone
Elsewhere in the pipeline, BASF is pushing the global commercialization of its Nemasphere soybean technology. Varieties carrying the trait are slated to become available in the US and Brazil from 2028, the company said on Monday.
In Louisiana, BASF officially commissioned its new MDI production facility at the Geismar integrated site on 11 November. The investment was pegged at roughly USD 1 billion, lifting the site's annual MDI capacity to around 600,000 metric tons.
The company also signed a sale agreement for its mining chemicals business with SNF on 12 November. Completion is expected in 2027, subject to regulatory approvals and customary closing conditions.
Evonik: Sweeteners, Not a Solution
The most closely watched item remains the potential Evonik takeover. According to Reuters, BASF is sounding out further commitments to the state government of North Rhine-Westphalia and the RAG Foundation, covering sites, jobs and apprenticeships, in a bid to win backing for the deal. A fresh offer could follow within days, according to a Bloomberg report cited by Reuters — though no new bid has been confirmed.
BASF at a turning point? This analysis reveals what investors need to know now.
Price is only part of the puzzle. Handelsblatt reports that 26–28 euros per share could be required, which Reuters calculates would mean extra costs of 0.9–1.8 billion euros versus the previous offer. Two people close to Evonik told Reuters that a higher price alone would not settle the matter; a convincing industrial rationale is also needed. For BASF shareholders, the risk is twofold — additional cost, and a strategic decision left hanging.
The 24 November Verdict
None of this makes the growth initiatives irrelevant. A methanol partnership that lowers project hurdles, a soybean trait with a 2028 launch window and a fully commissioned MDI train in Geismar all fit a constructive case for BASF's longer-term prospects. But they are building blocks, not proof of near-term profit.
The next real checkpoint is the capital markets day on 24 November 2026, where Patel expects agriculture to take centre stage. What matters then is not the number of new initiatives on display, but how credibly BASF can map a route to its earnings ambitions — and whether the market is willing to pay for the journey.
Ad
BASF Stock: New Analysis - 18 November
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
